Search results
Rethinking SUT’s environmental impact: Can single-use technology be sustainable?
Pharmaceutical Technology· 3 days agoThere is a widespread belief that single-use technology (SUT) is bad for the environment....
EAN 2024: Treatment cessation and reinitiation can reduce benefits of Ajovy
Clinical Trials Arena· 2 days agoThe results focused on the effects of treatment cessation and reinitiation. Ajovy is an...
Larvae survey, awareness on dengue prevention in Mysuru district - Star of Mysore
Star of Mysore· 9 hours agoMysuru/Bengaluru: In a bid to prevent and control the spread of dengue in the district, the Health...
Viral vector manufacturing: design considerations to improve commercial success
Pharmaceutical Technology· 3 days agoViral vector manufacturing: the key to the success of gene therapy Frost & Sullivan recently invited...
Zydus Life, Dr Reddy's partner to co-market Pertuzumab biosimilar for breast cancer treatment - CNBC...
CNBC TV18· 6 days agoGeneric drugmaker Zydus Lifesciences Ltd on Friday (June 28) said it has entered into a licensing...
27-yr-old youth dies due to dengue in Bengaluru
The Hindu· 5 days agoOf the two suspected deaths in the city due to dengue reported on Friday, an audit by the civic body on Saturday confirmed that the death of 27-year-old youth Abhilsh, a businessman and a resident ...
What Is Lymphoma, and Is It Serious?
Verywell Health· 3 days agoA Guide to Navigating Lymphatic Cancer Medically reviewed by Doru Paul, MDMedically reviewed by Doru Paul, MD Lymphoma is a type of blood cancer...
Coronavirus and COVID remain health threats. Get vaccinated this fall, CDC says.
Durham Herald-Sun· 4 days agoHow can we protect ourselves? The top recommendation from the CDC is to prepare to get vaccinated in...
EMA CHMP recommends approval for Roche’s PNH therapy
Pharmaceutical Technology· 4 days agoPiaSky, a recycling monoclonal antibody that inhibits the complement protein C5, has been recommended for use in PNH patients aged 12 years and above...
Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Pharmaceutical Technology· 7 days agoChina becomes the third country to offer LEQEMBI, following its introduction in the US and Japan. A...
